|
Volumn 22, Issue 2, 2003, Pages 281-288
|
A novel matrix metalloproteinase inhibitor, FYK-1388 suppresses tumor growth, metastasis and angiogenesis by human fibrosarcoma cell line.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
FYK 1388;
GELATINASE A;
GELATINASE B;
GUANIDINE DERIVATIVE;
HYDROXAMIC ACID;
PROTEINASE INHIBITOR;
TUMOR PROTEIN;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
CELL CULTURE;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG SCREENING;
ENZYMOLOGY;
FEMALE;
FIBROSARCOMA;
HUMAN;
INSTITUTE FOR CANCER RESEARCH MOUSE;
LUNG TUMOR;
METASTASIS;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
SUBCUTANEOUS DRUG ADMINISTRATION;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
FEMALE;
FIBROSARCOMA;
GUANIDINES;
HUMANS;
HYDROXAMIC ACIDS;
INJECTIONS, SUBCUTANEOUS;
LUNG NEOPLASMS;
MATRIX METALLOPROTEINASE 2;
MATRIX METALLOPROTEINASE 9;
MICE;
MICE, INBRED BALB C;
MICE, INBRED ICR;
MICE, NUDE;
MOLECULAR STRUCTURE;
NEOPLASM PROTEINS;
PROTEASE INHIBITORS;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
MLCS;
MLOWN;
|
EID: 0042662967
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.22.2.281 Document Type: Article |
Times cited : (12)
|
References (0)
|